Response to: Comment on “Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT)”

Podobne zapisy

• Response to: Comment on “Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT)”
  od: Sumati Gupta, i wsp.
  Wydane: (2025-05-01)
• Clinical, Genomic, and Transcriptomic Characteristics of Patients with Metastatic Renal Cell Carcinoma Who Developed Thromboembolic Events
  od: Gliceida Galarza Fortuna, i wsp.
  Wydane: (2024-07-01)
• Testosterone suppression and recovery in patients with advanced prostate cancer treated with intermittent androgen deprivation therapy with relugolix
  od: Patrick Campbell, i wsp.
  Wydane: (2024-11-01)
• Von Hippel Lindau syndrome: A systematic review of pharmaceutical treatments
  od: Gliceida M Galarza Fortuna, i wsp.
  Wydane: (2024-12-01)
• Effectiveness of Second-Line Cabozantinib in Metastatic Clear Cell Renal Cell Carcinoma Patients After First-Line Treatment with Immune Checkpoint Inhibitor-based Combinations
  od: Arshit Narang, i wsp.
  Wydane: (2024-09-01)